• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung].

作者信息

Kikuchi K, Ogata T

出版信息

Gan To Kagaku Ryoho. 1986 Jan;13(1):24-9.

PMID:3002284
Abstract

Between August 1982 and February 1985, 13 patients with pathological stage I non-small cell lung cancer received postoperative chemotherapy with ACNU, ADM and 5-FU. Nine patients had squamous cell carcinoma, two adenocarcinoma, and two large cell carcinoma. All patients were alive in August, 1985, but four of them had recurrent disease. The site of recurrence was the brain in three and the contralateral lung in one. Of these four patients, three had t2n0(-) p0 squamous cell carcinoma and one t1n0(-) p1 large cell carcinoma. In a control group consisting of six squamous cell carcinoma and six adenocarcinoma, recurrence occurred in one patient with t1n0(-) p0 squamous cell carcinoma. Although the treated group had unfavorable conditions of cell type and tumor size, there was no evidence that this combination chemotherapy could control recurrence of the tumor under these conditions.

摘要

相似文献

1
[Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung].
Gan To Kagaku Ryoho. 1986 Jan;13(1):24-9.
2
[Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].非小细胞肺癌术后化疗的临床价值——特别提及长期联合化疗联合免疫治疗
Gan To Kagaku Ryoho. 1985 Jan;12(1):21-35.
3
[Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].顺铂、阿霉素和丝裂霉素C联合化疗(PAM)治疗非小细胞肺癌
Gan To Kagaku Ryoho. 1986 Jun;13(6):2123-7.
4
Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy.化疗和放疗后III期肺癌的外科治疗
Jpn J Clin Oncol. 1994 Apr;24(2):101-5.
5
Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.术后辅助顺铂、长春地辛联合替加氟尿嘧啶化疗可提高完全切除的Ⅰ期非小细胞肺癌患者的生存率。
Lung Cancer. 2005 Jul;49(1):85-94. doi: 10.1016/j.lungcan.2004.11.025.
6
[Randomized systemic chemotherapy using two or three drug combination for small cell lung cancer (SCLC)].[采用两药或三药联合的随机系统性化疗治疗小细胞肺癌(SCLC)]
Gan No Rinsho. 1984 Feb;30(2):115-21.
7
Comparison of alternating to nonalternating chemotherapy regimens for non-small cell lung cancer.非小细胞肺癌交替化疗方案与非交替化疗方案的比较。
Cancer Treat Rep. 1986 Jun;70(6):711-4.
8
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.改良II期(T1 N1 M0、T2 N1 M0)非小细胞支气管源性癌的治疗。一种综合治疗方法。
J Thorac Cardiovasc Surg. 1983 Aug;86(2):180-5.
9
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.T1 N1 M0和T2 N1 M0期非小细胞肺癌切除术后辅助治疗的作用。
J Thorac Cardiovasc Surg. 1986 Mar;91(3):344-9.
10
[Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].依托泊苷、丝裂霉素C和环磷酰胺联合化疗治疗晚期非小细胞肺癌
Gan To Kagaku Ryoho. 1986 Jul;13(7):2399-403.